develop
past
two
decad
antisens
strategi
becom
technolog
recognis
therapeut
potenti
mani
problem
rais
earlier
applic
solv
vari
extent
howev
adequ
deliveri
antisens
oligodeoxynucleotid
individu
cell
remain
import
inordin
difficult
challeng
synthet
polym
appear
scene
middl
surprisingli
larg
varieti
use
propos
far
agent
deliveri
oligodeoxynucleotid
discuss
principl
antisens
strategi
certain
aspect
ingest
macromolecul
cell
present
situat
deliveri
procedur
articl
analys
detail
attempt
use
synthet
polym
carrier
matric
andor
cell
membran
permeabilis
agent
deliveri
antisens
oligodeoxynucleotid
structur
aspect
variou
polym
well
result
promis
limit
use
critic
evalu
r
treatment
tradit
drug
base
molecular
substitut
involv
chemic
modif
variou
compound
subject
screen
programm
increas
array
inherit
acquir
diseas
understood
insid
approach
involv
identif
target
underli
genet
caus
result
therapeut
strategi
base
addit
gene
compens
faulti
gene
addit
gene
new
function
disrupt
gene
express
develop
rapidli
grow
divers
scope
gene
therapi
treat
diseas
caus
malfunct
gene
transfer
genet
materi
cell
either
correct
genet
error
gene
target
introduc
new
function
therapeut
benefit
gene
augment
recent
year
wit
develop
gene
disrupt
technolog
one
approach
antigen
strategi
aim
either
inactiv
gene
homolog
recombin
dna
construct
disturb
gene
function
combin
short
fragment
dna
ie
oligodeoxynucleotid
odn
abl
form
tripl
helix
structur
differ
approach
tradit
drug
therapi
gene
therapi
andfto
certain
extentffrom
antigen
strategi
antisens
strategi
sometim
call
antimrna
antimesseng
odn
use
strategi
target
molecul
act
intermediari
genet
express
ie
messeng
ribonucl
acid
mrna
aim
inhibit
product
protein
technolog
make
use
short
fragment
nucleic
acid
molecul
commonli
odn
typic
nucleotid
long
fig
display
complementari
base
sequenc
target
mrna
abl
interact
ration
way
mrna
transcript
mutant
overexpress
gene
prevent
translat
diseaserel
protein
ideal
situat
mrna
molecul
vulner
select
attack
result
arrest
process
suppress
protein
biosynthesi
strategi
target
gene
transfer
genet
materi
involv
compar
tradit
drug
strategi
usual
nonspecif
use
odn
provid
high
specif
select
ideal
odn
precis
length
one
target
mrna
bind
target
sequenc
specif
consid
everi
singl
mrna
molecul
would
abl
gener
larg
multitud
protein
copi
unless
process
arrest
inhibit
gene
express
effici
specif
inhibit
result
protein
zamecnik
stephenson
first
propos
use
synthet
odn
therapeut
purpos
term
antisens
came
use
coin
izant
weintraub
last
two
decad
strategi
receiv
special
attent
due
ration
foundat
appar
eas
synthesis
use
odn
potenti
drug
recent
report
suggest
least
dozen
human
clinic
trial
odn
initi
sinc
direct
target
role
cancer
aid
inflammatori
disord
psoriasi
cytomegaloviru
retin
renal
transplant
reject
commerci
antisens
therapeut
product
fomivirsen
approv
fda
treatment
cytomegaloviru
retin
although
technolog
becom
establish
strategi
undisput
potenti
therapeut
power
controversi
regard
mechan
action
experiment
reproduc
well
issu
present
well
understood
slow
progress
field
difficulti
find
adequ
deliveri
method
odn
relat
cellular
nuclear
uptak
current
perceiv
one
major
drawback
number
ingeni
stratagem
develop
deal
problem
use
synthet
polym
carrier
odn
one
articl
attempt
provid
detail
account
structur
suitabl
limit
outcom
polym
propos
far
deliveri
odn
one
expect
problem
underli
deliveri
odn
strategi
significantli
differ
underli
nonvir
deliveri
dna
gene
therapi
latter
topic
extens
review
inde
mani
polym
carrier
present
also
tri
deliveri
dna
howev
size
dna
commonli
plasmid
consider
larger
oligonucleotid
make
cellular
nuclear
uptak
plasmid
difficult
creat
addit
technic
challeng
may
limit
rang
potenti
carrier
nonvir
deliveri
method
employ
gene
therapi
appear
less
effici
virusmedi
deliveri
principl
therapeut
action
follow
central
dogma
molecular
biolog
eukaryot
cell
comprehens
discuss
major
review
basic
assumpt
simpl
singlestrand
nucleic
acid
could
hybridis
nucleic
acid
result
blockag
normal
utilis
cell
latter
everi
gene
doublestrand
dna
carri
genet
inform
particular
protein
transcrib
cell
nucleu
copi
singlestrand
mrna
intermediari
carrier
inform
primari
transcript
socal
premrna
undergo
number
matur
process
becom
matur
mrna
transloc
cytoplasm
copi
mrna
serv
templat
biosynthesi
larg
number
molecul
particular
protein
translat
ribosom
protein
biosynthesi
apparatu
cell
lead
appear
phenotyp
determin
origin
gene
descript
ideal
mechan
would
odn
enter
cell
interact
specif
directli
molecul
complementari
mrna
odn
call
antisens
constitut
complementari
strand
portion
code
sequenc
gener
design
sens
strand
singlestrand
mrna
bind
odn
hydrogen
bond
usual
watsoncrick
base
pair
fig
form
doublehelix
hybrid
duplex
regard
odn
drug
affin
receptor
mrna
sequenc
result
two
process
hybridis
base
pair
base
stack
doubl
helix
form
specif
odn
drug
result
highli
select
natur
base
pair
hybridis
mrna
speci
becom
obsolet
translat
sever
possibl
caus
instanc
bind
odn
mrna
site
translat
start
prevent
bind
factor
initi
modul
translat
also
hybrid
format
may
block
movement
ribosom
along
mrna
molecul
progress
held
final
drop
translat
suppress
biosynthesi
protein
target
mrna
serv
templat
longer
possibl
fig
paterson
et
al
demonstr
mechan
first
time
cellfre
system
coin
term
hybridarrest
translat
hart
therapeut
consequ
obviou
aim
cancel
diseaserel
protein
translat
arrest
inde
inhibitori
mechan
major
odn
initi
design
howev
compel
experiment
evid
one
mechan
oper
besid
hart
mechan
odn
induc
effect
appear
complex
mani
might
even
numer
thought
fact
limit
number
case
true
antisens
inhibitori
action
rigor
demonstr
sinc
rather
littl
present
understood
contribut
variou
mechan
event
happen
odn
deliv
expos
nucleic
acid
receptor
treatment
oper
inhibitori
mechan
involv
socal
antisens
activ
would
remain
larg
theoret
beyond
aim
review
specialist
field
extens
discuss
mechan
attempt
rationalis
proven
put
mechan
led
classif
take
account
event
occur
process
mrna
may
inhibit
interven
odn
instanc
odn
interfer
event
preced
translat
take
place
nucleu
ie
transcript
case
target
dna
splice
matur
inhibitori
pathway
sometim
classifi
occupancymedi
mechan
categori
also
includ
hart
mechan
classifi
occupancymedi
destabilis
refer
inhibit
earli
posttranscript
key
step
process
premrna
order
assur
stabl
matur
mrna
premrna
must
undergo
cap
specif
protein
end
addit
polyadenyl
chain
end
interact
region
premrna
odn
inhibit
step
thu
destabilis
rna
speci
anoth
import
mechan
reli
activ
ribonucleas
h
rnase
h
group
ubiquit
enzym
specif
cleav
rna
strand
rnadna
duplex
rnase
hmediat
cleavag
effect
appear
commonli
accept
mechan
activ
odn
although
recognit
odn
substrat
rnase
h
restrict
due
high
sensit
structur
chang
odn
anoth
mechan
base
chemic
alter
target
nucleic
acid
oligonucleotid
bear
reactiv
speci
induc
alkyl
crosslink
oligonucleotid
conjug
complex
redoxact
metal
abl
gener
activ
oxygen
speci
specif
bind
cleav
target
nucleic
acid
henc
term
artifici
endonucleas
relat
latter
method
use
ribozym
attract
much
attent
ribozym
rna
speci
abl
catalys
cleavag
rna
speci
within
rnaribozym
duplex
therapeut
exploit
involv
attach
oligonucleotid
order
deliv
synthet
entiti
consist
antisens
domain
catalyt
domain
singleor
doublestrand
nucleic
acid
speci
known
aptam
bind
protein
regulatori
function
express
gene
final
nonspecif
effect
certain
sens
homopolymer
odn
observ
mani
instanc
suggest
intric
inhibitori
mechan
strictli
speak
mechan
antisens
process
definit
mechan
sequenc
specif
mrna
target
action
mani
mechan
sequenc
independ
andor
target
dna
protein
attempt
reconcil
discrep
envelop
adequ
larg
varieti
mechan
approach
commonli
cover
antisens
umbrella
term
leonetti
et
al
propos
gener
concept
synthet
small
nucleic
acid
interf
gene
express
snaig
apart
hart
mechan
mention
snaig
also
includ
disrupt
gene
express
triplehelix
format
hybridis
oligonucleotid
doublestrand
dna
clearli
antigen
strategi
aim
transcript
arrest
regardless
precis
mechan
action
still
matter
conjectur
case
case
advanc
strategi
afflict
major
problem
signific
progress
late
record
toward
solv
problem
stabil
odn
hybrid
nucleas
activ
target
select
specif
sequenc
access
biolog
activ
vivo
technic
feasibl
remain
predomin
challeng
abil
suitabl
deliv
odn
order
assur
maximum
cellular
permeabl
effect
internalis
improv
effici
reach
target
perhap
benefici
briefli
recapitul
known
process
eukaryot
cell
abl
ingest
eject
macromolecul
topic
routin
treat
cell
biolog
textbook
import
export
macromolecul
mainli
protein
particul
matter
low
molecular
weight
solut
across
plasma
membran
way
cell
continu
commun
environ
plasma
membran
key
factor
accumul
elimin
variou
compon
perform
task
transport
passiv
diffus
endocytosi
transport
process
membran
stationari
solut
mainli
low
molecular
weight
diffus
endocytosi
process
ingest
macromolecul
particul
matter
involv
format
membranebound
vesicl
discuss
releas
substanc
cell
exocytosi
yet
clear
role
process
intracellular
traffick
odn
endocytosi
consist
sequenti
inward
fold
plasma
membran
invagin
envelop
droplet
extracellular
medium
pinch
membran
format
intracellular
vesicl
contain
ingest
materi
vesicl
fuse
form
endosom
increas
size
maximum
nm
fuse
intracellular
vesicl
process
known
pinocytosi
differ
phagocytosi
endocyt
process
involv
ingest
bacteria
larg
particl
food
foreign
materi
specialis
cell
endosom
fuse
membranebound
organel
known
lysosom
contain
larg
amount
hydrolyt
enzym
endosom
fuse
primari
lysosom
form
secondari
lysosom
final
destin
internalis
macromolecul
target
degrad
ingest
materi
rapidli
broken
lysosom
enzym
endocyt
membran
return
plasma
membran
endosom
bypass
lysosom
travers
cytoplasm
transcytosi
either
incorpor
plasma
membran
releas
content
exocytosi
macromolecul
featur
recognis
membran
ingest
nonspecif
endocytosi
cell
eg
reticuloendotheli
system
perform
process
much
higher
rate
cell
eg
fibroblast
main
idea
retain
endosom
compart
cell
perform
import
task
sort
internalis
materi
degrad
lysosom
b
recycl
plasma
membran
c
transcytosi
usual
endocyt
cycl
begin
endosom
gener
small
invagin
occur
region
plasma
membran
coat
electrondens
structur
known
coat
pit
pit
pinch
membran
form
coat
vesicl
eventu
shed
coat
fuse
earli
endosom
main
protein
coat
clathrin
clathrinco
pit
invagin
becom
vesicl
entrap
extracellular
fluid
compon
internalis
process
call
fluidphas
endocytosi
anim
cell
clathrinco
pit
vesicl
provid
specialis
pathway
ingest
certain
macromolecul
cell
term
receptormedi
endocytosi
rme
specif
adsorpt
endocytosi
process
take
place
receptor
plasma
membran
bind
extracellular
macromolecul
ligand
receptorligand
complex
internalis
much
higher
rate
macromolecul
ingest
pathway
receptor
present
coat
pit
even
absenc
ligand
addit
receptor
accumul
bind
ligand
model
develop
explain
role
clathrin
accumul
receptor
coat
pit
clathrinmedi
pathway
appear
respons
major
rme
pinocyt
process
clathrinindepend
pathway
endocytosi
demonstr
sever
situat
pathway
may
proceed
via
small
nm
invagin
caveola
contain
specif
protein
caveolin
certain
receptor
smooth
uncoat
invagin
nm
process
term
potocytosi
appear
deposit
macromolecul
directli
cytosol
avoid
lysosom
compart
author
regard
nonendocyt
process
order
perform
inhibitori
task
odn
must
pass
plasma
membran
escap
cytoplasm
vesicl
reach
target
cytoplasm
nuclear
event
target
odn
must
also
enter
nucleu
howev
seriou
difficulti
plasma
membran
potent
natur
barrier
larg
molecul
neg
charg
molecul
surprisingli
although
odn
molecul
least
one
characterist
impli
littl
profici
diffus
across
membran
ingest
take
place
better
would
expect
instanc
demonstr
radiolabel
odn
ad
solut
serumfre
medium
human
cultur
cell
internalis
cell
within
min
uptak
nake
odn
gener
low
tell
biolog
effect
vitro
set
contrari
effect
attain
vivo
set
nake
odn
anim
experi
also
clinic
trial
tent
explan
advanc
appar
dichotomi
although
mani
aspect
ingest
odn
cell
yet
clarifi
compel
evid
enter
cell
endocyt
process
passiv
diffus
earlier
thought
pinocytosi
rme
nonspecif
adsorpt
endocytosi
endocytosi
mediat
membran
destabilis
amongst
pathway
suggest
demonstr
differ
experiment
condit
nonendocyt
process
eg
potocytosi
also
propos
identif
receptor
odn
role
rme
remain
elucid
number
cell
surfac
receptorlik
protein
yet
characteris
associ
internalis
odn
result
sometim
conflict
seem
affect
type
cell
experiment
condit
also
shown
cellular
uptak
intracellular
traffick
activ
odn
relat
phase
cell
cycl
ingest
mechan
appar
influenc
accord
author
two
aspect
internalis
odn
distinguish
cellular
uptak
releas
cytoplasm
nucleu
cellular
uptak
refer
bind
odn
plasma
membran
gener
ingest
cell
releas
cytoplasm
refer
amount
odn
actual
reach
compart
pharmacolog
activ
enter
cell
odn
accumul
endosom
lysosom
lysosom
predict
fate
degrad
howev
fraction
odn
escap
endosom
cytoplasm
mechan
complet
understood
efflux
may
take
place
simpl
diffus
unlik
transient
destabilis
endosom
membran
mediat
certain
membran
protein
leakag
fusion
event
two
vesicl
regardless
assum
observ
biolog
activ
due
small
amount
odn
manag
escap
endosom
releas
odn
may
transport
nucleu
eventu
enter
nucleu
may
interact
nuclear
dna
rna
speci
scenario
probabl
complex
appear
certainli
rais
addit
problem
pharmacolog
endosom
sequestr
odn
nonproduct
detour
lysosom
degrad
dead
end
facilit
endosom
escap
consequ
import
aim
variou
stratagem
improv
efficaci
odn
endosom
compartmentalis
complet
bypass
inject
odn
directli
cytosol
microinject
lead
rapid
accumul
nucleu
reason
microinject
experi
littl
signific
studi
compartmentalis
odn
internalis
endocytosi
penetr
nucleu
take
place
passiv
diffus
nuclear
pore
activ
signalmedi
diffus
former
pathway
possibl
macromolecul
exceed
kda
molecular
weight
case
contribut
nuclear
localis
signal
molecul
necessari
odn
seldom
exceed
kda
nuclear
uptak
pore
unlik
obstruct
although
intracellular
fate
odn
seem
favour
nuclear
localis
evid
distribut
nucleu
cytosol
conflict
result
regard
preferenti
distribut
may
rather
come
larg
variat
experiment
condit
notori
poor
reproduc
antisens
experi
mani
strategi
develop
enhanc
rate
andor
select
cellular
internalis
odn
attempt
make
intellig
vast
literatur
current
avail
topic
recent
review
classifi
deliveri
strategi
two
group
first
group
concern
cellular
uptak
process
includ
system
abl
promot
bind
odn
plasma
membran
either
protect
degrad
enhanc
interact
membran
system
includ
conjug
variou
compound
eg
cholesterol
odn
complex
odn
cation
compound
eg
cation
polym
encapsul
odn
eg
within
liposom
cyclodextrin
label
target
eg
intercal
agent
ligand
cellsurfac
receptor
odn
second
group
concern
entri
cytoplasm
nucleu
includ
system
abl
facilit
escap
endosom
cytoplasm
transfer
techniqu
eg
microinject
electropor
endosom
membran
destabilis
agent
eg
viral
peptid
fusogen
agent
strategi
use
alon
combin
everi
system
advantag
drawback
brief
overview
strategi
involv
synthet
polym
present
administr
nake
odn
infus
inject
variou
part
bodi
still
prefer
method
vivo
howev
requir
multipl
dose
experi
anim
show
nondamag
administr
rout
nasal
oral
dermal
patch
eye
drop
much
less
effici
odn
deliv
nake
molecul
microinject
cytoplasm
nucleu
technic
complex
procedur
mainli
achiev
cell
cultur
associ
poor
reproduc
unsatisfactori
error
rang
electropor
electrophoresismedi
techniqu
thought
feasibl
cell
line
cultur
also
may
induc
damag
cell
although
use
electropor
recent
readvoc
gene
therapi
report
applic
deliveri
odn
viral
deliveri
system
use
littl
extent
strategi
encapsul
incorpor
liposom
current
prefer
method
deliveri
odn
besid
intraven
infus
subcutan
intramuscular
intraocular
inject
nake
odn
probabl
method
use
human
clinic
trial
ultim
suspens
liposom
also
administ
infus
inject
liposom
microscop
close
vesicl
vari
nm
mm
diamet
consist
unilamellar
multilamellar
phospholipid
membran
surround
aqueou
space
odn
entrap
enhanc
cellular
uptak
odn
case
antisens
effect
report
larg
varieti
liposom
carrier
system
includ
anion
liposom
phsensit
liposom
immunoliposom
ie
contain
antibodi
direct
specif
cellsurfac
receptor
fusogen
liposom
ie
abl
merg
cellular
endosom
membran
cation
liposom
far
cation
lipid
frequent
use
strategi
extent
prepar
avail
commerci
eg
cytofectin
lipofectin
product
appear
activ
permeabilis
agent
destabilis
endosom
membran
use
cation
lipid
encapsul
necessari
step
easili
form
complex
odn
spite
popular
perceiv
liposom
investig
suffici
carrier
odn
also
limit
use
instanc
basic
tendenc
cation
liposom
accumul
reticuloendotheli
system
lead
short
life
serum
reduc
access
tissu
gener
size
liposom
practic
import
larg
surfac
charg
densiti
high
final
type
liposom
display
poor
encapsul
effici
wonder
search
carrier
ever
continu
one
result
associ
odn
synthet
polym
carrier
topic
present
articl
howev
skeptic
need
deliveri
system
odn
permeabilis
adjuv
employ
deliveri
system
interact
plasma
membran
reason
use
capac
consequ
receptor
signal
process
function
cell
may
serious
affect
aspect
properli
investig
import
question
also
aris
sinc
odn
deliv
without
carrier
still
display
activ
need
bother
develop
deliveri
system
repli
mani
report
indic
enhanc
therapeut
effect
odn
deliv
associ
adjuv
anoth
issu
associ
odn
carrier
increas
size
complex
particl
deliv
thu
limit
access
certain
target
even
contribut
degrad
repli
cite
reason
deliveri
system
employ
first
place
ie
increas
cellular
uptak
protect
degrad
improv
specif
nevertheless
debat
still
open
larg
size
odncarri
pharmacophor
toxic
carrier
improv
deliveri
system
odn
must
therefor
ongo
challeng
involv
strategi
research
one
reason
recognit
fact
way
odn
deliv
dramat
consequ
fate
demonstr
vitro
wagner
et
al
seri
eleg
experi
found
nake
odn
incub
cell
cultur
accumul
cytoplasm
vesicl
like
endosom
lysosom
nucleu
odn
microinject
directli
cytoplasm
cell
show
nuclear
localis
odn
deliveri
cell
cultur
took
place
via
cation
liposom
cell
show
nuclear
localis
odn
anoth
reason
probabl
import
albeit
seldom
acknowledg
need
sustain
deliveri
vivo
mani
studi
indic
although
odn
gain
access
target
tissu
vivo
elimin
rapidli
repeat
administr
requir
achiev
therapeut
effect
also
consid
biolog
activ
odn
need
maintain
addit
period
time
allow
decay
preexist
level
diseaserel
protein
vivo
deliveri
techniqu
chiefli
use
present
ie
infus
inject
nake
molecul
liposom
system
assur
adequ
longterm
mainten
odn
tissu
detail
overview
polym
carrier
use
strategi
attempt
section
experi
discuss
phosphorothio
phosphodiest
odn
employ
antisens
agent
prefer
former
due
enhanc
resist
enzymat
attack
natur
odn
play
howev
less
signific
role
choic
perform
carrier
unless
relev
issu
phosphorothio
phosphodiest
natur
odn
specifi
exposit
sinc
cellular
membran
neg
charg
cation
polym
receiv
attent
potenti
carrier
odn
coulomb
forc
govern
interact
plasma
membran
polyc
strong
influenc
properti
polym
eg
hydrophil
drastic
diminish
inde
varieti
cation
polym
abl
promot
internalis
odn
cell
type
describ
howev
cation
polym
constitut
ideal
solut
cell
line
take
odnpolym
conjug
reason
yet
elucid
also
seriou
concern
cytotox
posit
charg
polym
cation
carrier
must
contain
enough
charg
neutralis
odn
also
provid
suffici
residu
charg
interact
membran
cell
nevertheless
difficult
ascertain
much
residu
charg
enough
even
difficult
adjust
level
render
carrierodn
conjug
cytotox
hand
condit
contact
serum
posit
charg
carrier
might
never
enough
counterbal
neg
charg
serum
compon
internalis
conjug
prohibit
case
firstli
demonstr
cation
liposomeplasmid
dna
conjug
interact
nucleic
acid
basic
polyelectrolyt
process
known
long
time
kleczkowski
show
conjug
protein
nucleic
acid
gener
phenomenon
take
place
whenev
ph
allow
opposit
charg
also
suggest
interact
protein
viral
nucleoprotein
may
respons
reduc
infect
virus
time
investig
found
growth
bacillu
anthraci
inhibit
fraction
calf
thymu
well
deterg
benzylalkylammonium
chlorid
protein
histon
histon
thymu
fraction
polypeptid
high
content
amino
acid
llysin
studi
polylysin
pl
fig
lesser
extent
copolym
lysinevalin
shown
induc
agglutin
avian
erythrocyt
reduc
infect
type
influenza
viru
tobacco
mosaic
viru
induc
agglutin
bacteri
cell
electrostat
bind
cation
polypeptid
surfac
cell
virus
suggest
respons
mechan
find
later
confirm
greater
rang
polypeptid
bacteria
neutral
anion
peptid
show
effect
also
suggest
effect
cation
peptid
may
due
complex
mechan
includ
destabilis
cellular
membran
penetr
polym
cell
interact
nucleic
acid
polym
blockag
enzymat
process
effect
various
charg
peptid
agglutin
human
erythrocyt
attribut
mechan
earli
applic
polyc
develop
standard
procedur
assay
infecti
viral
nucleic
acid
base
observ
cation
polyelectrolyt
pl
polyornithin
por
fig
diethylaminoethyl
dextran
enhanc
substanti
infect
polioviru
singleand
multistrand
rna
promot
adsorpt
cell
peptideinduc
enhanc
viral
activ
notic
virus
regard
result
polyc
act
permeabilis
agent
enhanc
cation
polyelectrolyt
polynucleotideinduc
interferon
product
explain
mechan
anoth
applic
cation
polypeptid
pl
por
polyarginin
includ
use
model
compound
investig
interact
nucleic
acid
histon
speci
play
import
role
regul
genet
process
studi
suggest
bind
reaction
simpl
electrostat
neutralis
involv
steric
select
induc
stabilis
dna
expect
find
eventu
trigger
use
cation
polypeptid
carrier
transport
bioactiv
agent
ryser
group
harvard
medic
school
found
uptak
radiolabel
serum
albumin
cell
cultur
significantli
enhanc
presenc
protein
rich
lysin
synthet
peptid
obtain
lysin
l
ld
lornithin
lhistidin
conclud
process
must
simpl
result
electrostat
interact
suggest
polycationinduc
chang
structur
cellular
membran
surmis
previous
other
subsequ
investig
indic
individu
amino
acid
diamin
promot
effect
effect
polypeptid
relat
molecular
weight
distanc
amino
group
molecul
conclud
attach
cellular
membran
must
take
place
multipl
centr
later
studi
ryser
group
advoc
coval
bind
carrier
polypeptid
bioactiv
agent
cellular
uptak
drug
methotrex
consider
enhanc
bind
poli
llysin
pll
drug
releas
cell
pharmacolog
activ
form
potenc
increas
complex
drugpll
conjug
heparin
believ
facilit
endosom
escap
although
seldom
acknowledg
first
studi
effect
pll
cellular
uptak
polynucleotid
credit
schell
demonstr
pretreat
cell
pll
complex
polynucleotid
pll
enhanc
uptak
radiolabel
synthet
polyhomoribonucleotid
ehrlich
ascit
tumour
cell
mechan
suggest
base
interact
pll
cellular
membran
format
polynucleotidepl
complex
high
affin
cellular
membran
howev
decad
later
pll
eventu
consid
potenti
carrier
odn
deliveri
mainli
due
pioneer
work
lebleu
group
univers
montpelli
franc
demonstr
effici
pllodn
coval
conjug
sever
vitro
biolog
model
initi
dosedepend
inhibit
viru
growth
observ
conjug
pll
oligoadenyl
mediat
antivir
activ
interferon
administ
cell
cultur
infect
variou
virus
vesicular
stomat
vaccinia
etc
cell
take
free
oligoadenyl
clear
demonstr
pll
effici
permeabilis
agent
subsequ
group
show
odn
complementari
certain
region
vesicular
stomat
viru
nucleocapsid
protein
mrna
much
activ
cell
cultur
conjug
pll
time
rel
free
odn
provid
sequencespecif
dosedepend
antivir
activ
howev
also
notic
pll
cytotox
high
dose
ineffect
cell
line
use
fluoresceinlabel
odn
investig
demonstr
uptak
conjug
acceler
enhanc
compar
unconjug
odn
mechan
suggest
conjug
taken
cell
nonspecif
adsorpt
endocytosi
odn
releas
enzymat
degrad
lysin
moieti
conjug
sequest
within
acid
cytoplasm
compart
summaris
result
author
recommend
use
pll
order
assur
effici
deliveri
odn
pllodn
conjug
also
use
protect
infect
human
cell
line
patholog
effect
human
immunodefici
viru
type
significantli
reduc
product
viral
protein
studi
effect
pllodn
conjug
enhanc
complex
polyanion
heparin
tent
explan
advanc
reduct
pll
cytotox
modif
odn
releas
conjug
andor
interfer
heparin
viru
multipl
use
pll
strategi
partial
review
number
articl
still
advoc
larg
rang
synthet
pll
product
kda
avail
commerci
synthet
peptid
also
investig
carrier
coval
conjug
por
odn
evalu
cellfre
vitro
system
estim
capac
stimul
rnase
h
activ
effect
translat
complementari
radiolabel
mrna
test
show
enhanc
activ
porodn
conjug
compar
unconjug
odn
recent
copolym
lysin
serin
modifi
poli
ethylen
glycol
use
carrier
odn
target
craf
protein
mrna
pancreat
cancer
cell
vitro
antiprolif
effect
noncoval
complex
evid
free
odn
effect
targetlabel
strategi
use
pll
develop
independ
time
pll
propos
carrier
target
agent
tissuespecif
ligand
link
pll
abl
interact
specif
receptor
target
cell
wu
group
univers
connecticut
first
develop
glycoprotein
ligand
asialoglycoprotein
coval
coupl
pll
result
conjug
abl
function
carrier
deliveri
dna
odn
hepatoma
cell
vitro
vivo
solubl
odn
dna
pllasialoglycoprotein
conjug
effect
deliv
odn
dna
specif
target
cell
resist
nucleas
degrad
also
enhanc
substanti
although
investig
confirm
efficaci
pllglycoprotein
conjug
recent
research
suggest
direct
coval
bind
asialoglycoprotein
odn
exclud
use
pll
might
provid
effici
deliveri
system
pllligand
system
current
investig
deliveri
odn
anoth
approach
noncoval
pllodn
complex
incorpor
diffus
algin
nanoparticl
system
provid
protect
nucleas
degrad
also
deliv
effici
anim
organ
odn
target
mrna
retroviru
protein
pll
also
essenti
compon
socal
terplex
system
develop
deliveri
dna
odn
system
base
balanc
hydrophob
net
surfac
charg
nstearyl
pll
lipoprotein
dna
odn
deliv
vitro
system
cmyb
odn
mer
show
distinct
antiprolif
effect
cultur
smooth
muscl
cell
human
lung
fibroblast
unlik
pll
homopoli
amino
acid
mainli
employ
electroposit
charg
design
use
heteropeptid
prompt
transloc
properti
ie
abil
destabilis
endosom
membran
thu
facilit
releas
odn
molecul
cytoplasm
degrad
prevail
fusogen
peptid
perform
task
conform
chang
induc
increas
acid
follow
cytoplasm
compartmentalis
peptid
design
synthesis
use
model
hemagglutinin
envelop
protein
influenza
viru
biolog
activ
coval
conjug
odn
demonstr
vitro
variou
cell
line
anoth
peptid
prove
effect
permeabilis
agent
design
contain
hydrophob
domain
like
fusion
sequenc
hiv
protein
hydrophil
domain
like
nuclear
localis
sequenc
tantigen
fusogen
peptid
advantag
follow
natur
pathway
enter
cytoplasm
expens
produc
also
caus
immunogen
reaction
result
recent
studi
provid
even
pessimist
prospect
eighteen
fusogen
peptid
contain
membran
transloc
nuclear
localis
structur
motif
coval
bound
odn
complementari
initi
codon
region
firefli
luciferas
mrna
administ
stabl
cell
line
cultur
express
luciferas
activ
none
conjug
abl
inhibit
significantli
luciferas
express
formul
base
liposom
cytofectin
induc
expect
inhibit
studi
confoc
fluorescein
microscopi
show
conjug
entrap
endosom
author
conclud
addit
structur
motiv
fusogen
peptid
necessari
enabl
escap
endosom
attempt
rationalis
use
polyc
carrier
nucleic
acid
kabanov
et
al
extend
use
term
interpolyelectrolyt
complex
ipec
defin
watersolubl
product
spontan
assembl
dna
polyc
upon
mix
ipec
dna
molecul
chang
conform
becom
compact
henc
resist
nucleas
attack
polycation
compon
releas
dna
chain
competit
interact
element
cellular
membran
consider
rang
polyc
tent
use
deliveri
dna
gene
therapi
includ
pll
deriv
poli
salt
polyamidoamin
dendrim
polyethyleneimin
polym
methacryl
diethylaminoethyl
dextran
oligoc
spermidin
deriv
shown
articl
polym
use
far
strategi
dendrim
highli
branch
polym
globular
architectur
polyamidoamin
pamam
dendrim
fig
synthesis
welldefin
diamet
precis
number
termin
amino
group
branch
level
gener
haensler
szoka
jr
first
investig
use
carrier
dna
gene
therapi
subsequ
studi
demonstr
pamamdna
complex
abl
mediat
effici
transfer
plasmid
dna
variou
cell
type
vitro
far
pamam
dendrim
appli
littl
extent
carrier
odn
studi
odn
complementari
atg
region
pcmv
luciferas
plasmid
inhibit
luciferas
express
deliv
complex
pamam
dendrim
mous
melanoma
cell
embryon
fibroblast
odn
alon
neglig
effect
gener
ethylenediaminecor
dendrim
surfac
amino
group
mw
kda
effici
carrier
complex
charg
ratio
odn
dendrim
anoth
studi
uptak
fluoresceinlabel
phosphorothio
odn
human
astrocytoma
cell
enhanc
complex
gener
dendrim
charg
ratio
odn
distribut
cytoplasm
nuclei
polyethyleneimin
pei
fig
produc
acidcatalys
polymeris
aziridin
involv
propag
cyclic
immonium
cation
due
endgroup
reaction
high
reactiv
intermedi
immonium
speci
result
polym
usual
branch
pei
solubl
water
high
capac
charg
electroposit
everi
third
atom
ionis
nitrogen
pei
propos
carrier
odn
plasmid
dna
studi
rhodaminelabel
odn
target
translat
region
chicken
athyroid
hormon
receptor
success
deliv
embryon
chicken
hypothalam
neuron
complex
pei
uptak
free
odn
could
detect
interestingli
ingest
odn
almost
entir
localis
cell
nuclei
sinc
pei
episod
evalu
carrier
plasmid
dna
variou
cell
type
experiment
anim
littl
report
use
deliveri
odn
shown
complex
pei
improv
uptak
biolog
activ
phosphodiest
odn
target
differ
region
hara
mrna
untransl
region
craf
kinas
evalu
cultur
human
bladder
carcinoma
cell
contrari
liposom
deliveri
lipofectin
elicit
antisens
activ
probabl
nucleas
degrad
howev
complex
pei
phosphorothio
odn
stabl
taken
cell
without
releas
odn
therefor
abl
hybridis
show
antisens
activ
recent
report
fate
peidna
complex
cell
gener
relev
use
carrier
pei
perhap
cation
polym
care
conduct
experi
miko
et
al
follow
path
fluoresceinlabel
pei
pei
dna
complex
deliv
cultur
eahi
cell
line
mix
human
immortalis
cell
use
confoc
microscopi
found
complex
polym
particl
attach
cell
ingest
endocytosi
clump
cytoplasm
vesicl
grew
number
size
underw
disrupt
releas
content
signific
find
pei
particl
either
deliv
part
complex
dna
alon
eventu
localis
nuclei
order
structur
suggest
possibl
pei
cation
polym
may
interfer
advers
host
gene
rais
seriou
concern
use
human
therapi
cation
block
copolym
develop
carrier
dna
odn
kabanov
et
al
polyspermin
ps
poli
ethylen
oxid
peo
kataoka
et
al
pll
peo
conceptu
amphiphil
polym
consist
hydrophil
peo
shield
surround
hydrophob
polycation
core
abl
form
micellar
structur
dna
odn
term
block
ionom
complex
polyion
complex
micel
synthesi
block
copolym
quit
difficult
usual
accompani
high
polydispers
molecular
weight
purif
extrem
labori
addit
complex
odn
difficult
problem
larg
differ
size
two
macromolecul
drawback
like
prevent
extend
use
cation
block
copolym
carrier
odn
nevertheless
studi
clearli
indic
effici
instanc
pspeo
block
copolym
use
deliv
odn
complementari
splice
junction
herp
viru
type
earli
premrna
infect
vero
cell
cultur
inhibit
viru
reproduct
markedli
increas
compar
induc
free
odn
demonstr
pspeo
peipeo
block
copolym
form
easili
watersolubl
complex
odn
increas
resist
nucleas
degrad
anoth
studi
deliveri
odn
target
suppress
amphiphysin
complex
pspeo
block
copolym
significantli
success
cultur
hippocamp
neuron
recent
studi
pspeo
block
copolym
use
deliv
odn
target
fibronectin
mrna
vitreou
caviti
rat
eye
downregul
fibronectin
express
achiev
success
neutral
polym
posit
surfac
charg
induc
deliber
order
render
carrier
odn
base
principl
cation
polym
perform
better
due
neg
charg
cell
membran
posit
charg
gener
polystyren
nanoparticl
perform
emuls
polymeris
presenc
cation
initi
azobi
dihydrochlorid
azobi
propan
dihydrochlorid
nanoparticl
thoroughli
characteris
size
distribut
surfac
charg
colloid
stabil
cytotox
adsorpt
desorpt
odn
complex
four
differ
odn
observ
resist
nucleas
degrad
complex
odn
increas
significantli
compar
free
odn
although
total
desorpt
odn
particl
achiev
ad
ionic
surfact
author
conclud
cation
polystyren
nanoparticl
could
function
suitabl
deliveri
system
odn
howev
vitro
vivo
experi
report
date
polycyanoacryl
pca
fig
neutral
polym
form
nanoparticl
made
suitabl
function
carrier
odn
gener
posit
charg
entiti
surfac
abl
mediat
electrostat
adsorpt
odn
format
ion
pair
unlik
cation
polystyren
describ
charg
surfac
pca
part
chemic
structur
polym
introduc
system
time
complex
odn
investig
commenc
group
centr
nation
de
la
recherch
scientifiqu
pari
provid
result
current
avail
mediat
ionpair
format
hydrophob
cation
quaternari
ammonium
salt
tetraphenylphosphomium
chlorid
propos
major
experi
cetyltrimethylammonium
bromid
ad
odn
prior
complex
polym
nanoparticl
also
demonstr
absenc
cation
neglig
amount
odn
complex
pca
suggest
ionpar
cation
agent
bind
polym
hydrophob
interact
ionic
moieti
bind
electrostat
odn
experi
show
resist
nucleas
degrad
intracellular
concentr
odn
consider
enhanc
complex
via
ionpair
agent
pca
system
employ
far
includ
poli
isobutyl
cyanoacryl
poli
isohexyl
cyanoacryl
group
achiev
signific
success
deliveri
certain
odn
instanc
complex
odn
target
point
mutat
codon
hara
mrna
inhibit
prolifer
cell
express
mutat
gene
concentr
time
lower
free
odn
inhibit
tumour
growth
mice
inject
oncogenecarri
cell
anoth
experi
odn
complementari
vesicular
stomat
viru
nucleocapsid
protein
mrna
ingest
effici
human
macrophagelik
cell
stabil
greatli
improv
complex
sinc
high
concentr
ionpair
agent
elicit
cytotox
reaction
attempt
made
remov
system
coval
modifi
odn
hydrophob
moieti
cholesterol
coval
conjug
adsorb
onto
pca
nanoparticl
absenc
ionpair
cation
howev
modif
odn
reduc
activ
recent
studi
transient
posit
charg
gener
surfac
poli
nhexyl
cyanoacryl
nanoparticl
use
diethylaminoethyl
dextran
emuls
stabilis
polymeris
fluoresceinlabel
odn
complementari
splice
junction
herp
viru
type
premrna
complex
nanoparticl
deliv
cultur
vero
cell
free
odn
almost
complet
degrad
cultur
medium
adsorb
odn
remain
intact
effect
ingest
cell
demonstr
laser
scan
confoc
microscopi
flow
cytometri
use
neutral
polym
came
exist
like
cation
polym
prove
ideal
carrier
odn
deliveri
due
especi
intrins
cytotox
interact
electroneg
cellular
membran
neutral
polym
may
facilit
internalis
process
polymerodn
conjug
neutral
polym
use
abil
act
carrier
system
assur
sustain
releas
long
term
odn
molecul
rather
role
may
play
process
cellular
uptak
latter
essenti
reduc
case
problem
ingest
free
odn
molecul
howev
neutral
polym
conjug
odn
principl
ingest
cell
pinocyt
process
whether
physic
chemic
bond
odn
polym
cleav
ingest
conjug
issu
littl
investig
synthet
hydrogel
epitom
soft
polymer
biomateri
caus
insignific
damag
soft
tissu
howev
applic
deliveri
odn
class
gel
known
trade
name
pluron
poloxam
attract
attent
investig
due
revers
thermal
gelat
properti
watersolubl
materi
uncrosslink
block
copolym
poli
ethylen
oxid
poli
propylen
oxid
fig
particular
composit
block
sequenc
acquir
unusu
properti
liquid
ambient
low
temperatur
becom
gel
physiolog
temperatur
live
tissu
block
copolym
suppli
basf
corpor
subject
two
report
regard
use
carrier
odn
studi
treatment
vasculoprolif
diseas
odn
target
cmyc
cmyb
mrna
incorpor
solut
pluron
administ
cultur
vascular
smooth
muscl
cell
surgic
insert
around
denud
carotid
arteri
rat
deliveri
system
assur
effici
vitro
cellular
uptak
odn
reduc
cellular
prolifer
inhibit
vivo
hyperplasia
effect
sinc
anoth
system
offer
prolong
deliveri
odn
effici
vivo
see
section
conclud
releas
durat
gel
short
attempt
improv
liposom
deliveri
odn
vitreou
bodi
eye
couvreur
et
al
dispers
liposom
mixtur
odn
aqueou
solut
copolym
latter
chosen
presumpt
form
gel
temperatur
eye
influenc
copolym
concentr
releas
profil
radiolabel
model
odn
oligothymidyl
cellfre
vitro
set
investig
studi
found
releas
liposom
content
could
control
vari
concentr
pluron
medium
howev
concentr
eventu
drop
copolym
solubl
water
inde
solubl
water
seem
major
drawback
class
polym
carrier
odn
ultim
carrier
dispers
surround
physiolog
medium
rate
high
proper
sustain
releas
unlik
presenc
affect
mechan
odn
ingest
crosslink
hydrogel
abl
absorb
larg
amount
water
dissolv
also
attract
attent
possibl
carrier
odn
aim
produc
artifici
vitreou
substitut
group
lion
eye
institut
western
australia
develop
crosslink
hydrogel
homopolymeris
vp
copolymeris
methacryl
hema
materi
display
viscoelast
behaviour
could
inject
needl
common
size
prove
lack
cytotox
also
show
serumlik
growth
promot
effect
anchoragedepend
cell
line
mous
fibroblast
static
cultur
hypothesis
latter
due
physic
protect
cell
hydrogel
abil
hydrogel
mimic
extracellular
matrix
physic
protect
may
involv
interact
polym
cell
membran
way
harm
cell
conceiv
hydrogel
particl
come
close
cell
even
contact
membran
without
destabilis
affect
cell
function
background
group
design
crosslink
copolym
vp
hema
coval
bound
odn
target
human
rhodopsin
gene
code
mutat
amino
acid
protein
conjug
subject
cellfre
vitro
releas
experi
day
presenc
natur
bovin
vitreou
humour
compar
control
enzym
present
signific
amount
odn
releas
hydrogelodn
conjug
possibl
explan
presenc
enzym
contain
natur
vitreou
humour
may
cleav
coval
bond
induc
releas
odn
directli
inject
gel
system
attract
intravitr
deliveri
odn
investig
progress
polyest
produc
cyclic
monom
contain
lacton
structur
moieti
long
histori
use
biodegrad
biomateri
class
mainli
includ
polyest
made
polycondens
llactid
glycolid
caprolacton
dioxanon
cyclic
carbon
deriv
polylactid
polyglycolid
respect
known
also
poli
lactic
acid
pla
poli
glycol
acid
pga
investig
biodegrad
polym
also
found
applic
carrier
odn
akhtar
group
aston
univers
birmingham
uk
first
propos
pla
fig
purpos
radiolabel
odn
target
splice
region
tat
gene
hiv
mrna
aug
initi
codon
human
cmyc
oncogen
exon
incorpor
within
chloroformcast
film
pla
releas
profil
monitor
day
cellfre
serum
buffer
media
releas
data
correspond
kinet
case
diffus
monolith
devic
includ
initi
burst
releas
plaentrap
odn
resist
degrad
serum
nucleas
free
odn
rapidli
degrad
serum
group
develop
p
lacoga
microspher
mm
size
evalu
vitro
odn
employ
preced
studi
incorpor
microspher
doubleemuls
solvent
evapor
method
releas
profil
studi
buffer
media
microspher
contain
radiolabel
odn
also
administ
cultur
mous
macrophag
cell
raw
line
found
cellular
uptak
enhanc
diffus
intracellular
intranuclear
distribut
odn
occur
deliv
microspher
releas
durat
larger
microspher
much
longer
smaller
one
investig
vitro
seri
odn
show
great
advantag
p
lacoga
microspher
regard
releas
characterist
enhanc
resist
nucleas
attack
effici
system
independ
confirm
use
deliv
odn
complementari
translat
initi
start
region
rat
tenascin
mrna
led
inhibit
prolifer
migrat
vascular
muscl
cell
cultur
investig
use
cylindr
implant
p
lacoga
attempt
improv
deliveri
odn
vitreou
humour
eye
odn
complementari
translat
initi
codon
region
herp
simplex
viru
mrna
incorpor
cylind
p
lacoga
heat
appropri
mould
implant
contain
mg
odn
releas
studi
buffer
media
incub
bovin
vitreou
fluid
doublefilt
natur
humour
determin
molecular
weight
polym
affect
durat
releas
amount
odn
releas
vitreou
fluid
lower
buffer
solut
presum
due
enzymat
degrad
odn
poli
ethylen
glycol
peg
term
use
polyoxyethylen
polym
low
molecular
weight
term
poli
ethylen
oxid
prefer
design
polyoxyethylen
high
molecular
weight
convent
rather
obscur
gener
overlook
acronym
peg
use
throughout
section
regardless
molecular
weight
peg
constitut
class
watersolubl
polym
mani
applic
crosslink
peg
behav
like
typic
hydrogel
form
employ
carrier
variou
drug
deliveri
formul
howev
use
deliveri
odn
base
hydrogel
peg
chain
incorpor
coval
chemic
modifi
order
mask
ident
odn
protect
recognit
nucleas
b
enhanc
cellular
penetr
due
probabl
chain
structur
peg
oligonucleotid
chemistri
shortchain
peg
insert
nonnucleotid
flexibl
linkag
triplexform
odn
synthet
ribozym
duplexand
triplexform
dna
construct
longerchain
peg
use
agent
solidphas
synthesi
odn
effect
peg
bind
odn
cellular
internalis
investig
first
time
summerton
et
al
seri
short
odn
complementari
portion
ccucc
sequenc
prokaryot
ribosom
rna
test
e
coli
bacteri
cell
cultur
order
detect
inhibitori
effect
protein
synthesi
unmodifi
odn
manifest
effect
ml
cell
strain
lack
outer
cell
wall
ineffect
cell
normal
membran
permeabl
properti
pegmodifi
odn
show
substanti
inhibitori
effect
normal
cell
coloni
author
surmis
peg
chain
assist
penetr
odn
outer
cell
wall
remov
enzymat
cleavag
anoth
studi
peg
chain
attach
larg
number
odn
properti
result
conjug
thoroughli
investig
hybridis
capac
alter
presenc
peg
chain
resist
phosphodiesteras
increas
consider
similar
result
report
studi
compar
resist
nucleas
specif
bind
activ
odn
three
modif
ie
phosphodiest
phosphorothio
pegmodifi
phosphodiest
author
also
investig
retent
plasma
three
odn
intraven
administr
mice
pegmodifi
phosphodiest
odn
display
retent
time
longer
phosphodiest
unmodifi
phosphorothio
odn
display
far
longest
retent
develop
new
solidphas
synthet
procedur
largescal
synthesi
odn
use
peg
solubl
polymer
support
higheffici
liquid
phase
help
made
possibl
product
odn
mer
contain
peg
moieti
variabl
molecular
weight
kda
use
method
pegmodifi
odn
target
mrna
synthesis
odn
moieti
coval
conjug
maintain
normal
hybridis
capac
display
enhanc
resist
phosphodiesteras
nucleotidas
degrad
howev
antisens
activ
yet
report
homopolym
n
methacrylamid
hpma
copolym
extens
studi
carrier
sitespecif
target
deliveri
drug
shown
hpmabas
polym
exhibit
littl
immunogen
pinocytos
cell
distribut
organ
excret
molecularweightdepend
manner
polym
subject
detail
investig
howev
awar
one
studi
regard
use
hpma
polym
carrier
odn
studi
copolym
hpma
n
ethylmethacrylamid
pdtema
fig
conjug
coval
sulfhydryl
group
fluoresceinlabel
odn
antihiv
uptak
conjug
cultur
hela
cell
examin
confoc
microscopi
rel
free
odn
cellular
uptak
conjug
slightli
enhanc
conjug
internalis
mainli
endosom
presenc
peptid
transloc
properti
bound
copolym
enhanc
cellular
uptak
presum
electrostat
associ
peptid
odn
prevent
interact
cell
membran
studi
previous
discuss
see
section
shown
odn
target
cmyc
mrna
incorpor
solut
watersolubl
polym
pluron
implant
around
carotid
arteri
rat
fail
show
antisens
effect
ie
inhibit
hyperplasia
odn
incorpor
poli
ethylenecovinyl
acet
fig
maintain
inhibit
durat
experi
copolym
known
evac
elvax
hydrophob
elastom
releas
incorpor
agent
slowli
due
hydrophob
properti
low
rate
aqueou
diffus
evac
copolym
first
nonhydrogel
polym
use
sustain
deliveri
biomacromolecul
time
gener
believ
larg
molecul
could
releas
polym
concern
later
express
regard
loss
biolog
activ
biomacromolecul
basic
fibroblast
growth
factor
follow
incorpor
evac
loss
attribut
contact
dichloromethan
solvent
mandatori
prepar
evacbas
deliveri
system
cyclodextrin
cd
fig
compris
group
watersolubl
cyclic
polysaccharid
contain
glucos
unit
linkag
acd
bcd
gcd
respect
glucos
unit
avail
commerci
cyclic
structur
provid
intern
hydrophob
coneshap
caviti
surround
hydrophil
shell
contain
larg
number
hydroxyl
group
due
conform
cd
deriv
readili
form
complex
larg
varieti
compound
consequ
investig
carrier
drug
first
studi
applic
odn
deliveri
complex
hydroxypropyl
hydroxyethyl
bcd
radiolabel
fluoresceinlabel
odn
prepar
uptak
human
cell
leukemia
cell
line
investig
compar
free
odn
uptak
increas
time
within
h
presenc
odn
detect
intracellularli
stabil
nucleas
affect
complex
cd
anoth
studi
seri
deriv
bcd
gcd
produc
complex
odn
phosphodiest
phosphorothio
target
initi
region
mrna
code
spike
protein
contain
intergen
consensu
sequenc
bovin
enter
coronaviru
antivir
activ
complex
investig
human
adenocarcinoma
tumour
cell
line
odn
show
antivir
activ
deliv
free
molecul
phosphodiest
induc
viral
inhibit
compar
phosphorothio
howev
activ
phosphodiest
markedli
improv
complex
bcd
complex
odn
bcd
deriv
molar
ratio
led
viral
inhibit
rather
surpris
anion
polym
attract
much
attent
potenti
carrier
odn
plausibl
reason
lie
misconcept
anion
polym
would
strongli
repel
cell
membran
charg
electroneg
case
howev
summaris
other
result
pitha
reveal
differ
situat
anion
polym
adsorb
cell
much
greater
extent
neutral
polym
abl
creat
open
cell
membran
quantit
term
membran
singl
cell
bind
pg
cation
polym
bind
pg
anion
polym
pg
neutral
polym
nevertheless
also
demonstr
anion
polym
increas
uptak
protein
cell
applic
date
anion
polym
deliveri
dna
odn
involv
use
crosslink
poli
acryl
acid
hydrogel
hydroplu
use
standard
angioplasti
polyethylen
balloon
cathet
coat
hydrogel
dna
imbib
diffus
hydrogel
coat
deliv
arteri
wall
rabbit
balloon
angioplasti
employ
ident
devic
investig
incorpor
hydrogel
layer
odn
target
cmyb
mrna
examin
effect
smooth
muscl
cell
prolifer
porcin
iliac
carotid
arteri
underw
angioplasti
cathet
one
week
later
immunohistochem
analysi
isol
arteri
segment
reveal
less
cell
prolifer
antisensetr
arteri
compar
sens
odn
control
although
rel
success
applic
exampl
sustain
deliveri
nake
odn
aqueou
diffus
hydrogel
involv
interact
neg
charg
polym
carrier
plasma
membran
target
cell
polym
possess
conjug
pelectron
backbon
chain
unusu
electron
properti
instanc
readili
oxidis
reduc
dope
acceptor
donor
electron
process
turn
insul
materi
electroconduct
one
case
approach
conduct
level
metal
great
potenti
electr
conduct
conjug
polym
larg
varieti
practic
applic
led
vast
investig
literatur
regard
synthesi
properti
applic
materi
oligonucleotid
chemistri
origin
develop
electrochem
control
synthesi
conduct
polym
film
contain
odn
copolymeris
pyrrol
pyrroleodn
coval
conjug
perform
electrochem
result
deposit
electrod
solid
film
contain
graft
odn
shown
odn
maintain
hybridis
capac
film
effici
detect
point
mutat
synthet
dna
construct
investig
went
produc
electr
conduct
polym
film
contain
odn
sole
intent
use
deliveri
odn
film
poli
pedot
fig
produc
electrod
subsequ
electrooxidis
presenc
odn
releas
entrap
radiolabel
odn
buffer
solut
monitor
sever
day
initi
burst
releas
electrostat
surfacebound
odn
remain
odn
releas
slowli
diffusioncontrol
manner
perhap
immedi
obviou
use
polym
deliv
odn
cell
repres
exampl
applic
biomateri
inde
use
synthet
polym
orthopaed
prosthes
heart
valv
intraocular
lens
contact
lens
mention
major
applic
seem
present
problem
littl
noth
common
ingest
similar
polym
individu
cell
realiti
applic
synthet
polym
strategi
particular
instanc
principl
biomateri
scienc
must
use
design
extrem
specif
set
properti
enabl
polym
perform
uniqu
task
assist
certain
biomacromolecul
reach
intracellular
space
unalt
biolog
activ
surprisingli
larg
varieti
synthet
polym
use
propos
carrier
antisens
therapeut
strategi
unlik
gene
therapi
viral
deliveri
system
still
prefer
two
aspect
use
polym
carrier
odn
one
implic
sustain
releas
physic
incorpor
coval
bound
odn
govern
either
aqueou
diffus
chemic
degrad
rel
classic
field
studi
aspect
involv
intric
cooper
discret
polymer
matter
plasma
membran
cell
bring
problem
seldom
encount
previous
applic
biomateri
spite
profus
research
none
polym
carrier
develop
far
abl
replac
convincingli
deliveri
system
infus
inject
free
liposomeencapsul
odn
although
propos
carrier
cation
polym
biodegrad
polym
show
promis
result
perhap
attent
concentr
futur
combin
truli
function
fusogen
peptid
cation
neutral
polym
also
work
need
clarifi
influenc
carrier
biodegrad
event
take
place
cell
surfac
ingest
process
howev
fact
outcom
far
decis
help
establish
polym
shall
carrier
choic
rather
moot
point
review
clearli
demonstr
consist
ever
increas
interest
polymeraid
deliveri
therapeut
odn
bring
hope
biomateri
applic
success
forthcom
futur
new
gener
drug
therapi
advanc
stage
develop
antisens
strategi
await
suitabl
deliveri
system
order
live
promis
